Bibliome.ai browser hg19
Search
About
Stats
FAQ
RET c.2428_2430delinsTGA ;(p.G810*)
Variant ID: 10-43615014-GGC-TGA
NM_020975.4(
RET
):c.2428_2430delinsTGA;(p.G810*)
This variant was identified in 4 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
A comprehensive overview of the relationship between RET gene and tumor occurrence.
Frontiers In Oncology
Zhao, Lu L; Wang, Na N; Zhang, Dou D; Jia, Yingjie Y; Kong, Fanming F
Publication Date: 2023
Variant appearance in text: RET: G810X
PubMed Link:
36865807
Variant Present in the following documents:
Main text
fonc-13-1090757.pdf
View BVdb publication page
RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.
Cancers
Kucharczyk, Tomasz T; Krawczyk, Paweł P; Kowalski, Dariusz M DM; Płużański, Adam A; Kubiatowski, Tomasz T; Kalinka, Ewa E
Publication Date: 2022-10-27
Variant appearance in text: RET: G810X
PubMed Link:
36358717
Variant Present in the following documents:
Main text
cancers-14-05298.pdf
View BVdb publication page
RET signaling pathway and RET inhibitors in human cancer.
Frontiers In Oncology
Regua, Angelina T AT; Najjar, Mariana M; Lo, Hui-Wen HW
Publication Date: 2022
Variant appearance in text: RET: G810X
PubMed Link:
35957881
Variant Present in the following documents:
Main text
fonc-12-932353.pdf
View BVdb publication page
Kinase drug discovery 20 years after imatinib: progress and future directions.
Nature Reviews. Drug Discovery
Cohen, Philip P; Cross, Darren D; Jänne, Pasi A PA
Publication Date: 2021-07
Variant appearance in text: RET: G810X
PubMed Link:
34002056
Variant Present in the following documents:
Main text
41573_2021_Article_195.pdf
View BVdb publication page